Balchem Corporation announced that James C. Hyde, Senior Vice President and General Manager, Human Nutrition and Health, has notified the Company of his intent to retire from his role and that James will step down upon the appointment of his successor. Mr. Hyde is expected to stay on for a transition period and retire from the Company in 2023. There are no material changes to Mr. Hyde's compensatory arrangement as a result of his planned retirement from his current role.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
145 USD | +0.91% | -0.41% | -2.50% |
Mar. 29 | Balchem Corporation Announces Management Changes | CI |
Mar. 12 | Balchem Insider Sold Shares Worth $840,985, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.50% | 4.64B | |
+10.74% | 62.7B | |
-5.85% | 45.31B | |
+14.21% | 39.92B | |
+17.59% | 26.04B | |
+4.11% | 17.99B | |
+0.46% | 17.29B | |
+4.93% | 15.65B | |
-23.40% | 15.56B | |
-20.96% | 13.2B |
- Stock Market
- Equities
- BCPC Stock
- News Balchem Corporation
- Balchem Corporation Announces Retirement of James C. Hyde as Senior Vice President and General Manager, Human Nutrition and Health